Skip to main content

#160511

Anti-Ly-49A [YE1/32.8.5]

Cat. #160511

Anti-Ly-49A [YE1/32.8.5]

Cat. #: 160511

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Ly-49A

Class: Monoclonal

Application: IP ; FACS

Reactivity: Mouse

Host: Rat

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Fumio Takei

Institute: BC Cancer

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Ly-49A [YE1/32.8.5]
  • Research fields: Cancer;Immunology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 44 kDa
  • Reactivity: Mouse
  • Host: Rat
  • Application: IP ; FACS
  • Description: The Ly-49A is a 44 kDa, type II transmembrane protein with disulfide-linked homodimers and external C-type lectin domains. Ly-49A is present on the surface of mouse NK cells with the purpose to inhibit NK cell activation by recognition and interaction with certain MHC-1s on target cells. The Ly-49A receptor recognizes H-2Dd and H-2Dk.
  • Immunogen: ECA17.9.8 cells
  • Isotype: IgG2b
  • Myeloma used: Y3

Target Details

  • Target: Ly-49A
  • Molecular weight: 44 kDa
  • Target background: The Ly-49A is a 44 kDa, type II transmembrane protein with disulfide-linked homodimers and external C-type lectin domains. Ly-49A is present on the surface of mouse NK cells with the purpose to inhibit NK cell activation by recognition and interaction with certain MHC-1s on target cells. The Ly-49A receptor recognizes H-2Dd and H-2Dk.

Applications

  • Application: IP ; FACS

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Takei et al. 1997. Immunol Rev. 155:67-77. PMID: 9059883.
  • Takei et al. 1983. J Immunol. 130(6):2794-7. PMID: 6304191.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.